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Abstract
There is a notable dearth of data about Hepatitis B Virus (HBV) and Hepatitis C Virus(HCV) prevalence in
Afghanistan. Awareness program and research capacity in the field of hepatitis are very limited in Afghanistan.
Number of vulnerabilities and patterns of risk behaviors signal the need to take action now.
Thirty one studies dating from October 2003 to 2011 were included, consisting the data of 1,32,981 individuals for
HBV and 1,32,500 individuals for HCV. Percentage prevalence was 1.9% for HBV and 1.1% for HCV in all available
Afghanistan population. Most at risk population to hepatitis include injecting drug users who share needles and
female sex workers, while truck drivers, prisoners and homosexual men needs attention, as their statistical figure
are missing. Data suggests that high incidence of intravenous drug use, sexual activities, unsafe blood transfusion
procedures and mobility are major risk factors for hepatitis transmission.
This review is based on analysis of the limited available data in Afghanistan. Although there are many underlying
vulnerability factors, it appears that Afghanistan remains at an early epidemic phase. Further research is required to
determine the seroprevalence and prevalent genotype(s) of HBV and HCV in all provinces in Afghanistan. This
article provides some key insights into the potential and likely future transmission dynamics of Hepatitis which will
serve as a guide in the identification of priority areas in term of high risk groups and risk behaviours in the country
and will assist to develop urgent strategic plans to combat the future burden of Hepatitis in Afghanistan.
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Introduction
Both HBV and HCV are major cause of dreadful liver dis-
eases including acute hepatitis, chronic liver diseases and
hepatocellular carcinoma [1]. It is estimated that 30% of
the global population (about 2 billion persons) have sero-
logic evidence of HBV infection while over 350 million
people are carriers of chronic HBV worldwide [2].
Approximately 3% of the world’s population (approxi-
mately 170 million people) have chronic hepatitis C virus
(HCV) infection and 3-4 million people are newly
infected annually [3].
Afghanistan is the world’s 41st largest country of about
28,150 million inhabitants [4] and fertility rate of 6.5 chil-
dren per woman [5]. It is among the least developed
countries in the world, with hampering factors like por-
ous borders, generally low levels of education and literacy
rate, and limited health and social infrastructure. Over
the past few decades, Afghanistan has endured wide-
spread armed conflict resulting in extensive internal and
external displacement of people, and social and economic
upheaval [4]. Hundreds of thousands of people are
internally displaced by conflict and natural disasters,
residing in camps and cities across Afghanistan. In addi-
tion, external displacement is also significant, particularly
refugees to neighbouring countries including Iran and
Pakistan [6], which harbor higher infected population of
HBV and HCV [7,8]. Higher prevalence of hepatitis
viruses has been reported among Afghan refugee popula-
tions outside of Afghanistan [9] may raise the concern of
elevated prevalence of hepatitis within the country.
Due to more than 20 years of political and wartime
unrest, the information about epidemiology of HBV and
HCV in Afghanistan has become completely out of date.
Insofar as it is possible through the use of existing limited
data, this article addresses the epidemiology of HBV,
HCV and genotypes and identification of risk factors in
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Afghanistan. The main objective of this article is to
inform policy makers and program managers about
trends in HBV and HCV rates and risk behaviours over
time across different regions and population groups
which are very useful for developing proper preventive
guidelines and educational programs.
Literature search
All available data of interest till the writing of this review
article from 2003 to March 2011 were searched for in
PubMed database of the National Library of Medicine,
National Institutes of Health (USA), using two search stra-
tegies: (Hepatitis and Afghanistan) and (HBV or HCV or
Blood Borne and Afghanistan). Inclusion criteria entailed
the studies demonstrating the prevalence, genotypes and
risk factors of HBV and HCV in the Afghanistan popula-
tion. To provide a simple review of the current situation,
thirty one different articles/abstracts/reports were
obtained from different sources, including national and
international reports and scientific publications. Data from
these articles regarding study time period, region (city and
province), study population, total sample size, and percen-
tages and numbers of HBV and HCV positive cases were
extracted. All literature identified by search were read and
categorized into 2 groups: A) Prevalence of HBV and
HCV in various population B) HBV and HCV genotyping
and C) High risk groups and risk behaviour.
A. Prevalence of HBV and HCV in various
populations
Few studies have addressed the prevalence of HBV and
HCV from different areas of the country in the various
population of Afghanistan. Identification and compari-
son of data in this article helps the decision makers
reach a better understanding of the current picture
among subpopulation throughout the country.
i. Injecting Drug Users (IDUs)
Only two studies dealing with the frequency of HBV
among IDUs were found, covering 1,087 IDUs from
Kabul, Hirat, Jalalabad, and Mazar-i-Sharif cities from
period of June 2005 to 2010. HBV serofrequency in
these individuals ranged from 5.8-6.5%, with an overall
prevalence of 6.15% [10,11].
Three studies from period of June 2005 to 2010 covering
1,696 IDUs from Kabul, Hirat, Jalalabad, and Mazar-i-
Sharif cities showed a range of 36.0-36.6% HCV serofre-
quency. The mean frequency was 36.4% and 1.5% were
found co-infected with HIV and HCV [10-12]. The data
on the disease burden in this large high-risk population
are limited while growing number of IDUs in Afghanistan
places the country at great risk for epidemics of hepatitis
in future.
ii. Intrapartum patients
The study in 2006-2007 was among the first and last till
the writing of this article to assess prevalence of hepatitis
B surface antigen (HBsAg) and HCV in 4,452 obstetric
populations admitted at three Kabul hospitals for obste-
tric indications. A survey found 1.53% positive cases of
HBsAg and 0.3% cases of HCV and none was positive for
both. It was concluded that prevalence rate was lower,
probably because this study comprised only those women
who were able to access care, likely belonged to higher
socioeconomic status. Because hepatitis has been asso-
ciated with lower socioeconomic status, the prevalence
rate reported in this study may underestimate the true
prevalence among reproductive-aged women in Kabul.
Prevalence of the infection among the antenatal popula-
tion may be a reliable indicator of general population
prevalence. The intrapartum period of the antenatal
population may be the only clinical access point in a vari-
ety of limited resource settings thus their routine surveil-
lance should be considered important [8].
iii. Sex workers
In only one study the HBV and HCV serofrequency in
520 Female Sex Workers (FSWs) from Jalalabad, Kabul,
and Mazar-i-Sharif was investigated. The prevalence rate
of HCV was 1.92%, and HBV was 6.54% in this sub-
group [13]. However, no study in male sex workers was
identified.
iv. Blood Donor and General Population
Blood donor prevalence data is one of the published
sources of population-based prevalence data [8]. 1,25,832
blood donors were tested by Central Blood Bank Kabul
and its provincial branches during the years 1989-2005 and
reported 2,221 (1.76%) were positive for HBsAg and 795
(0.63%) for HCV (Table 1). Central Blood Bank reported
HBsAg in 3.9% and anti-HCV in 1.9% Afghanistan blood
donors from March to December 2006. Blood donor pre-
valence data is one of the published sources of population-
based prevalence data [8,14]. More recent data about the
blood donors are not available. There is no information on
the prevalence rates of Hepatitis amongst general popula-
tion due to the absence of sentinel surveillance sites and
case reporting systems in Afghanistan. Studies of Hepatitis
prevalence conducted in blood donor populations may not
truly represent the prevalence in general population. Preva-
lence in blood donors may be an underestimate the preva-
lence if potential donors with a high-risk profile (like
history of jaundice, injection drug use, multiple sexual part-
ners, etc.) are screened out by questionnaires. Conversely,
prevalence may be an overestimate the general population
prevalence if professional blood donors were included, who
are often IDUs and selling blood for money [15].
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v. Health Care Workers (HCWs)
Only one published data was found addressing the HBV
infection in 113 HCWs from obstetrics-gynecology and
pediatric staff, Women’s Hospital, Kabul in 2005. The
survey reported that 23% HCWs had evidence of pre-
vious exposure to HBV. This survey was unable to test
HCWs for HCV, but concerned that it may also be pre-
sent as comorbid conditions since HCV share transmis-
sion patterns with HBV. Only two studies pertained to
HBV vaccination status. In 2004 only 8% reported a his-
tory of previous hepatitis B immunization [16] and
recently 27.9% HCWs in 10 national public hospitals in
Kabul had not vaccinated against HBV [17].
vi. Afghan refugees
Refugees may differ from the general population which
might affect their risk of HBV infection. For example,
the circumstances those lead to refugee status including
fleeing from violence and their socioeconomic status as
they have the resources and opportunity to leave their
country of origin. The prevalence rate of HBsAg was
4.1% and 5% among Afghan refugees in the United
States between 1979-1991 and 2007-2008, respectively
[18] and 60.8% (45/74) among Afghan refugees in
Dalaki, Iran [19]. In 2003, out of 903 Afghan refugees in
Balochistan, Pakistan, 8.3% (95% CI: 6.6-10.3) were
found positive for HBsAg.
Most of the Afghan refugees in USA were of higher
socio-economic class living and one of the probable rea-
sons of high seroprevalence of HBsAg among refugees
in Baluchistan was due to increased use of unsafe injec-
tion practices and higher socio-economic status of most
of refugees in USA probably with better healthcare
behavior [9]. Their higher status could potentially lessen
Table 1 Positive serologic tests done in the central bank and its Provincial branches during the years 1989-2005
Years Tested Areas Total tested HCV HBS
1996 Central Blood Bank 5309 6 71
1997 Central Blood Bank 3942 10 50
1998 Central Blood Bank 4221 16 97
1999 Central Blood Bank 7964 13 137
2000 Central Blood Bank 6844 1 280
2001 Central Blood Bank 6691 0 114
2002 Central Blood Bank 11586 4 248
2002 Parwan 581 0 5
2002 Mazar-e-Sharif 964 0 32
2003 Central Blood Bank 10674 54 173
2003 Nangarbar 3629 57 194
2003 Mazar-e-Sharif 4714 0 12
2004 Central Blood Bank 10514 80 190
2004 Nangarhar 3525 90 238
2004 Baghlan 232 0 9
2004 Mazar-e-Sharif 2147 1 17
2004 Heart 2890 3 6
2004 Jozjan 1264 1 77
2004 Logar 888 5 45
2004 Badakshan 256 1 18
2005 Central Blood Bank 7684 206 107
2005 Nangarhan 2145 148 49
2005 Heart 2185 23 4
2005 Mazar-e-Sharif 1190 7 1
2005 Juzjan 584 42 2
2005 Parwan 168 8 0
2005 Kunar 11 1 0
2005 Qandahar 1867 2 7
2005 Kunduz 826 16 38
Total Blood samples tested for HBV and HCV till 2005 125,832 795 2221
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the likelihood of HBV infection, because prevalence has
been shown to be inversely related to socioeconomic
status [18].
B. HBV and HCV genotypes
Hepatitis B is present everywhere in Asia and is ende-
mic in Afghanistan [20]. While the most prevalent HBV
genotype reported in southeastern Asia is D [21]. Only
one study based on small sample sizes (N = 12) revealed
that HBV genotype D, sub-genotype D1 (98% bootstrap
value), and serotype ayw2 were found among HBV
infected patients in Afghanistan [22]. No study is avail-
able on geographic variation in the prevalence of various
HBV and HCV genotypes and their routes of transmis-
sion from Afghanistan.
C. High risk groups and risk behaviour
Several issues are related to estimate risk for specific
causes of Hepatitis in world but still in Afghanistan the
evidence for its causes are scanty. An effort is made to
better understand and identify the risk factors which are
important for setting up control measures in the
country.
i. Socio-Economic aspects of country
Afghanistan is the second least developed country in the
world [23] and falls at the bottom of the 177 countries
according to the Human Development Index [6]. Unem-
ployment, political instability, poverty and low literacy
are linked to initiation of injecting and sex trade [24]. In
Kabul unemployment were found to be independent
risk factors for HCV among younger injectors [25] and
90% commercial sex workers (CSWs) gave poverty as
the reason of their involvement in sex work [6].
ii. Drug abuse and needle or syringe sharing
Throughout the world about 8-16 million HBV and 2.3-
4.7 million HCV infections may result from unsafe
injections annually [26]. About 50 - 100% of IDUs are
anti-HCV positive globally, thus constitute one of the
potential reservoirs in community [27]. 88% of the
world’s opium supply in 2005 was recorded from Afgha-
nistan, the main center of opium production [10]. Drug
dependency continues to increase equally across rural
and urban areas due to widespread and easy access to
cheap drugs and limited access to drug treatment, com-
bined with three decades of war-related trauma have
resulted in problem drug-use among almost one million
Afghans, roughly 8% of the population. It was stated
that approximately 2 out of every 1,000 urban adult
men were identifiable IDUs. Overall, 1,465 active IDUs
were mapped in the Kabul, Jalalabad and Mazar-i-Sharif
and expected significant increase in the number of drug
users [24].
Increase in injection drug use and needle sharing pave
the way for the spread of hepatitis infection [10]. 87% of
IDUs had shared needle and syringe with other injectors,
60% used needle and syringe that had been already used
by 2-5 people [28]. It is highlighted the need of drug coun-
seling and educational efforts to older drug users who
have not yet initiated injecting and to young IDUs to avert
infection and reduce risky drug use behaviors [25].
iii. Sexual activities and unsafe sex
Sexual transmission of infection is more frequent among
high-risk sexual behaviors groups such as multiple sex-
ual partners [27], working as a prostitute, homosexuals
and non-protected sexual contact [6,24]. FSWs in
Afghanistan are highly vulnerable, diverse and generally
have much larger sexual networks. There were about 1.9
FSWs per 1,000 women only in Kabul, Mazār-i-Sharif
and Jalalabad cities [24], 84% of FSWs had 1-2 clients/
day [4] and with 15 clients/month, 200 FSWs will have
3,000 sexual encounters/month, and more than 35,000/
year [24] with stark predictions that the number will be
on rise as women and girls resort to selling themselves
to escape poverty [4]. Some truck drivers do engage in
homosexual sexual relation with their generally young
conductors (assistants) [6]. Male IDUs also reported
having both commercial sex and sex with other men
[24]. CSWs are sexual partners of IDU and at time IDU
themselves [6]. Behavior of multiple sexual partners
seems to be very important in Afghani IDUs and truck
drivers, which may spend long periods away from home
and family and play as a source of infection for the
whole community [6].
Limited use of condom was reported in the country
[29]. A survey in 2005 reported less than 1% use of con-
doms among CSWs [6], in 2009 only 17-32% of IDUs
used condom in their last sexual encounter (in last
6 months) and in 2009 only 51% of truck drivers who
buying sex used condoms [4]. Globally street children
have been considered a high risk group for acquiring
and transmitting infectious diseases like HIV because
their lifestyle and daily struggle for food, shelter and
safety may lead them to provide sexual favours to obtain
the necessities of life or to drug taking, to dull the
impact of hardness of life [6] and still no data exist
regarding to them.
iv. Occupational exposure in Health care settings
HCWs are dealing with contaminated blood, blood-
related products and exposure prone procedures. Occu-
pation injuries in healthcare settings have been well
described in the literature as a major mode of transmis-
sion of HBV and HCV in developing countries [2].
HCWs in Afghanistan are particularly disadvantaged
due to decades of neglect of their personal health care
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and widespread inadequate infection control practices in
country, as well as no precise national data on the num-
ber of needle sticks. WHO modeled was applied to
world census which showed that about 66,000 HBV and
16,000 HCV infections may result from occupational
sharps in HCWs each year. For the country grouping in
which Afghanistan is placed, these estimates are 6,800
for HBV and 3,200 for HCV. These figures were shown
to be substantially lower in regions where strict efforts
have been made to reduce occupational exposures [16].
In a survey, 72.6% hospital staff reported sharps injury
in the preceding 12 months, mainly from hollow-bore
needle injuries (46.3%), particularly during re-capping
(24.5%) [17]. The medical histories and current symp-
toms were all self-reported and, in some cases, may
represent under-reporting [16].
v. Unsafe health care practices
HCV has been considered a potential health hazard for
military troops and veteran, because reliable screening of
blood products became possible in 1993 in Afghanistan
and still remains little developed [30]. Large parts of the
population do not have access to screening therefore
blood transfusions had undertaken without any screen-
ing. About 60,000 transfusions are usually documented
annually with 12000-16,000 in Kabul alone, of which not
more than 30% of blood donations were screened [6].
Consequently the poor state of blood transfusion facilities
throughout the country is of primary concern in the con-
trol of the spread of Hepatitis and AIDS [6]. No systema-
tic data on the prevalence of transmitted infections are
available due to absence of surveillance in Afghanistan.
vi. Mobile groups (refugees, internally displaced persons
(IDPs), truck drivers and migrant workers)
Rapid population mobility and migration is reducing the
differences in infectious disease epidemiology between
different regions of the world [31]. In Afghanistan cer-
tain mobile populations particularly refugees and IDPs
are at higher risk of infection for various reasons,
including exposure to sexual abuse, violence, and lack of
access to information and education [6]. It is evidence
that high proportions of IDUs are mobile across interna-
tional borders to Iran and Pakistan where hepatitis is
epidemics in IDU population. It could hasten the initia-
tion of epidemics in Afghanistan [32]. However, there
are no systemic data available on prevalence of hepatitis
amongst Afghan mobile population.
Afghans comprise the second largest number of refu-
gees and IDPs in the world. Currently, an estimated
440,000 people were displaced by conflict and natural
disasters across Afghanistan [24]. Because of returning
refugees, the population of Kabul has increased to ≈3
million since 2001, and estimated 470 IDUs in 2003 [8].
High influx of returning refugees is also said to be a fac-
tor of bringing the virus with them [9].
Most of IDUs Afghan had traveled outside Afghani-
stan in the previous 10 years [8]. Almost 69% of IDUs
in Mazar-i-Sharif and 80% in Jalalabad had lived outside
Afghanistan. This is an area of critical concern that
neighbour countries have reported outbreaks of hepatitis
among IDUs [24], may place other communities at risk
upon their return [8].
About 1,000,000 population leave Afghanistan for
working purposes annually to neighboring countries
consisting significant burden of blood born infection [6].
About 60,000 domestic truck drivers and 2,000 are
international truckers in Afghanistan [4]. International
experience suggested that truck drivers do engage the
services of CSWs and generally use drugs to overcome
fatigue associated with the long hours of long distance
driving. Sex industry trends to be most flourished in
mover’s destination location [6,31]. The evidence
showed that population mobility has an independent
risk factor for spread of infectious diseases, because they
can transfer the disease to the other places where they
move to. Afghan truck drivers is high risky group for
acquiring and transmitting HIV as they travel along
such routes and into neighbor countries, all of which
have large or developing sexually transmitting infection
problems [6]. Despite of high-risk behavior, no preva-
lence data is reported for HBV and HCV among them
Workers from neighbouring countries also come into
Afghanistan to work but no data available on risk beha-
viours and prevalence of hepatitis amongst Afghan
migrant workers [6].
vii. Prisoners
Imprisonment is the strongest predictors of hepatitis in
some areas of Asia [32]. Prisons are extremely high-risk
environments for infectious disease because of over-
crowding, poor nutrition, limited access to health care,
continued drug use and unsafe injecting practices,
unprotected sex and tattooing. In 2007, 10,590 prisoners
and detainees were reported in 35 prisons of Afghani-
stan [4] and 126 female prisoners were in Kabul prison,
of which 60-70 were arrested due to involvement in sex
work [24]. In most cases prisons are linked to the shar-
ing of injecting equipment and to unprotected sexual
encounters as access to clean needles and condoms are
limited there [6]. One third of Afghan IDUs had been
reported drug injection in prison [8,11,29].
viii. Knowledge
The basic knowledge of universal precaution was insuffi-
cient across all investigated hospitals and cadres in
Kabul [17,33]. 72.1% of obstetric patients and 91.1% of
HCWs were aware of HBV while correct transmission
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knowledge of HBV was found in 1.9% for patients and
33.9% for HCWs in Afghanistan [33]. In a survey in
Kabul, obstetric care providers underutilize testing of
sexually transmitted infections for antenatal patients in
Afghanistan, due to presumed rarity of infections and
due to logistical and cultural barriers [34].
Discussion
There has been paucity of community based epidemio-
logic work in Afghanistan. Very few studies have
addressed the magnitude of HBV and HCV in the high-
risk population including IDUs, FSWs, blood donors
and Afghan refugees living in the various parts of the
world. There are many areas where research cannot be
carried out at all, including general population, house-
hold contacts of HBV and HCV infected patients, multi-
transfused population of patients with thalassemia or
hemophilia, patients undergoing chronic dialysis. With-
out a deeper engagement with all these population, it is
difficult to offer extensive programmatic guidance for
their safe guard. Significant work is required to conduct
a comprehensive mapping to identify the prevalence rate
in Afghanistan. Due to lack of data from large parts of
county, exact figures are missing, thus stringent efforts
are required for national surveillance to assess the exact
situation. The country seems to be at an early phase of
HBV and HCV prevalence, but there are a number of
underlying vulnerability factors that could lead to the
conditions for epidemic, including war instability, huge
population displaced internally and externally, drug traf-
ficking, extremely low socio-political and economic sta-
tus, a fledgling health care system, and a low level of
knowledge and awareness about hepatitis.
Over three decades of protracted armed conflicts have
caused massive increases in poverty, insecurity and the
breakdown of social structures in the country [16]. It
facilitated a dramatic increase of illegal production and
marketing of opiates. Although non-injection use of
opium (smoking, vaporization, or oral ingestion) is tradi-
tional in Afghanistan, as with analgesic and relaxing
properties considering it a potential source of relief for
all kinds of stress. But the intensification of the war on
drugs through the reduction in heroin availability may
push more drug users towards injecting [8]. In study in
2003, 50% of participants had started using heroin in
either Pakistan or Iran [15,27].
Among the various routes of transmission, shared nee-
dles by IDUs is considered the key driver in Afghanistan
[8]. Almost 80% of IDUs are known to be mobile, that
they had changed residence at least once and 70% of IDUs
had shared needles [4]. Furthermore, HCV infected IDUs
were more likely to have had injections from non-medical
providers, which has been linked to Pakistan [8]. Further-
more, this is a disturbing finding as IDUs often trade sex
for drugs. Individuals who fall into both categories are
therefore particularly vulnerable to HBV and HCV and are
perhaps doubly stigmatized [28]. The immigration of
populations from neighboring countries of high endemic
of the infection seems to contribute significantly to the
rapid modification of epidemiological data. The high-risk
behavior of injection drug use in refugees may place com-
munities at risk upon their return [10]. IDUs are numer-
ous in society, though they have been inadequately studied
and limited data suggest the likelihood that the prevalence
of hepatitis is very high in this community.
The main problems in country are high rate of illiter-
acy, unawareness about sexually transmitted diseases and
low use of condoms among the IDUs and sex workers
that could lead to spill-over to other high risk groups and
from there to the general population [4]. Moreover,
extremely poor health structure regarding blood transfu-
sion and universal precautions would seem favorable to a
rapid spread of this disease if there is not urgent inter-
vention. Providing occupational safety and health training
to HCWs is one avenue to improve security [16]. It leads
officials to warn of the urgent need of the effective pro-
grams for early interventions to prevent the spread of
hepatitis in Afghanistan. There is a need to focus on
behavioral sentinel surveillance activity and inventory
program for the improvement of HBV and HCV aware-
ness and prevention in country as a matter of urgency.
Conclusion
Currently no systematic country wide data is available
about the actual prevalence rate of HBV and HCV and
its genotypes. In order to delineate the risk groups of
HBV and HCV it is necessary to conduct epidemiolo-
gical studies that depict an accurate frequency of the
disease in the subpopulation. A high proportion of
IDU in Afghanistan are mobile across international
borders to Iran and Pakistan suggests that linkages to
hepatitis epidemics in IDU in those countries could
hasten the initiation of epidemics in Afghanistan.
There is the risk that IDU may spread viral hepatitis
from to the general public, and then propagated
through unprotected sex alongside needle-sharing and
unscreened blood transfusion. This situation needs to
be addressed immediately, as a policy and political
prime issue at the country and all community levels.
Drug addicts and unsafe sex activities should be of
prime importance as the targets of disease prevention
and control programs and are considered as mobile
source of disease transmission.
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